Journal of Clinical Medicine · 16 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
In a retrospective single-center case series of 17 patients with malignant esophageal fistulas, all self-expandable metallic stent (SEMS) placements were technically successful, and 82.4% of patients were able to resume oral intake of semisolid or solid food with only one major adverse event.
All procedures were technically successful. After SEMS placement, 14 of 17 patients (82.4%) achieved a dysphagia score of 2 or less, enabling consumption of semisolid or solid food. Only one major adverse event (stent-induced fistula, 5.9%) was observed; the most common minor adverse events were chest pain (35.3%) and fever (29.4%). The median survival after SEMS placement was 71 days (range 17–247 days).
